Psychiatrists are frequently asked about the potential uses of cannabis and cannabinoid products to treat mental illnesses. To help inform members and educate the public, the CPA has systematically reviewed the existing literature on RCTs examining potential beneficial uses of cannabis and cannabinoid products to treat mental illness in adults. Read the statement.